FDC Limited (FDC) — Announcement | 24 April 2026(2 announcements)

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Announcement Neutral 📄 PDF

FDC Limited announced a postal ballot and remote e-voting process for appointing Mr. Kishore Saletore as Independent Director, with voting open from April 28 to May 27, 2026, alongside reporting strong Q1 FY26 financials of ₹2,301.02 crores total income and [amount context mismatch] crores net profit, up from previous year.

2 Announcement Neutral 📄 PDF

FDC Limited confirmed it does not qualify as a Large Corporate under SEBI's debt issuance framework as of March 31, 2026, submitting an undertaking to stock exchanges. The filing includes an annexure confirming zero outstanding borrowings and no credit rating history, marking a material change from prior periods where the company may have been classified differently. This status affects future regulatory obligations but carries no immediate financial impact or guidance.

About FDC Limited (FDC)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹5,534.73 Cr P/E: 18.9 ROE: 12.8% ROCE: 17.3% Div Yield: 1.47%

View full FDC stock details →

📡 Get AI alerts when FDC files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FDC — Free

📊 More FDC filings

See all FDC filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FDC files new disclosures

Track FDC filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track FDC — Free

Free account · 2 AI queries/day